← Leaderboards
Donald E Pogorzelski
Volatylix, Inc.
$3,300,000
Attributed
$3,300,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2018–21$1M$750K$500K$250K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$3,300,000 · 1
By mechanism
R44$3,300,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Evaluation”
- Valerie Koch · University Corporation For Atmospheric Res$265,601,376
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,645,551
- Beth Baseler · Leidos Biomedical Research, Inc.$208,220,586
- John E West · University Of Texas At Austin$131,399,667
- Kimberly Smith · Ppd Development Lp$115,671,664
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,805,377
Research focus
EvaluationEngineeringAntifungal TherapyDiagnosticDiagnostic TestsAntifungal AgentsBaseBiopsyAccurate DiagnosisCalibrationAspergillusCertificationCessation Of LifeComplexCostCulture TechniquesDangerousnessDesignBreath TestsAspergillosisDevice Or Instrument DevelopmentDevicesCaringFungal Drug Resistance
Grant awards (4)
A Rapid Breath Test for Invasive Aspergillosis$1,000,000
R44 · FY2021 · AI · contact PI
A Rapid Breath Test for Invasive Aspergillosis$1,000,000
R44 · FY2020 · AI · contact PI
A Rapid Breath Test for Invasive Aspergillosis$1,000,000
R44 · FY2019 · AI · contact PI
A Rapid Breath Test for Invasive Aspergillosis$300,000
R44 · FY2018 · AI · contact PI